New Insights in the Landscape of Rare Tumors: Translational ...
books.google.com
... Elisa Tavanti †, Maria Pia Patrizio, Serena Vella, Amira Fernandez-Ramos, Federica Magagnoli, Silvia Luppi, Claudia Maria Hattinger and Massimo Serra* ...
Targeting polo-like kinase 1 by NMS-P937 in ProQuest
search.proquest.com
by V Sero · · Cited by 32 — Valeria Sero & Elisa Tavanti & Serena Vella & Claudia Maria Hattinger &. Marilù Fanelli & Francesca Michelacci & Rogier Versteeg & Barbara ... › openview › 1.pdf
Valsasina, Barbara | DeepDyve
www.deepdyve.com
PRECLINICAL STUDIES Valeria Sero & Elisa Tavanti & Serena Vella & Claudia Maria Hattinger & Marilù Fanelli & Francesca Michelacci ...
Targeting ABCB1 and ABCC1 with their Specific PubMed
pubmed.ncbi.nlm.nih.gov
by M Fanelli · · Cited by 48 — Authors. Marilù Fanelli, Claudia Maria Hattinger, Serena Vella, Elisa Tavanti, Francesca Michelacci, Beth Gudeman, Daryl Barnett, Piero Picci, Massimo Serra ... by CM Hattinger · · Cited by 16 — Authors. Claudia M Hattinger , Serena Vella , Elisa Tavanti , Marilù Fanelli , Piero Picci , Massimo Serra. Affiliations. › ...
Targeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging...
www.ncbi.nlm.nih.gov
Serena Vella,#1Elisa Tavanti,#1 Claudia Maria Hattinger,1 Marilù Fanelli,1 Rogier Versteeg,2 Jan Koster,3 Piero Picci,1 and Massimo Serra1, ...
SpringerCitations - Details Page
citations.springernature.com
Claudia Maria Hattinger, Marilù Fanelli, Elisa Tavanti, Serena Vella, Stefano Ferrari, Piero Picci and Massimo Serra. Journal: Expert Opinion on Emerging Drugs ...
All web results to the name "Elisa Tavanti"
Cisplatin Resistance in Osteosarcoma: In vitro Validation of ...
moh-it.pure.elsevier.com
Marilù Fanelli, Elisa Tavanti, Maria Pia Patrizio, Serena Vella, Amira Fernandez-Ramos, Federica Magagnoli, Silvia Luppi, Claudia Maria Hattinger, ... › fingerprints
Cited by CrossRef (24) - BLOOD RESEARCH
www.bloodresearch.or.kr
Claudia Maria Hattinger, Maria Pia Patrizio, Elisa Tavanti, Silvia Luppi, Federica Magagnoli, Piero Picci, Massimo Serra. Genetic testing for high-grade ... › journal › citedBy
Current Cancer Drug Targets, Volume Number 3
benthamscience.com
Marilù Fanelli, Claudia Maria Hattinger, Serena Vella, Elisa Tavanti, Francesca Michelacci, Beth Gudeman, Daryl Barnett, Piero Picci and Massimo Serra. › journals › volume › issue
Eribulin Mesylate | Clinical Cancer Research
clincancerres.aacrjournals.org
Nov 1, — Claudia Maria Hattinger, Marilù Fanelli, Elisa Tavanti, Serena Vella, Stefano Ferrari, Piero Picci, Massimo Serra. › article-info
Molecular biology - PLOS ONE
journals.plos.org
Serena Vella, Elisa Tavanti, Claudia Maria Hattinger, Marilù Fanelli, Rogier Versteeg, Jan Koster, Piero Picci, Massimo Serra. published 29 Nov › ... › Molecular biology
Publications - CBA Pharma
www.cbapharma.com
Valeria Sero, Elisa Tavanti, Serena Vella, Claudia Maria Hattinger, Marilù Fanelli, Francesca Michelacci, Rogier Versteeg, Barbara Valsasina, Beth Gudeman, ... › publications
Targeting ABCB1 and ABCC1 with their Eurekaselect
www.eurekaselect.net
Author(s): Marilù Fanelli, Claudia Maria Hattinger, Serena Vella, Elisa Tavanti, Francesca Michelacci, Beth Gudeman, Daryl Barnett, Piero Picci and Massimo ... › article
Targeting polo-like kinase 1 by NMS-P937 in osteosarcoma ...
www.semanticscholar.org
Sep 7, — ... author={Valeria Sero and Elisa Tavanti and Serena Vella and Claudia Maria Hattinger and Maril{\`u} Fanelli and Francesca Michelacci and ... › paper › figure
正反馈回路SP1 / MIR17HG / miR-130a-3p促进骨肉瘤 X-MOL
www.x-mol.com
Marilù Fanelli,Elisa Tavanti,Maria Pia Patrizio,Serena Vella,Amira Fernandez-Ramos,Federica Magagnoli,Silvia Luppi,Claudia Maria Hattinger,Massimo Serra. › paper
Jan Koster - Publications List
publicationslist.org
Serena Vella, Elisa Tavanti, Claudia Maria Hattinger, Marilù Fanelli, Rogier Versteeg, Jan Koster, Piero Picci, Massimo Serra (2016) Targeting CDKs with ...
sorted by relevance / date